Taiji Matsusaka Selected Research

Kidney Diseases (Kidney Disease)

11/2022	Dicarbonyl-modified lipoproteins contribute to proteinuric kidney injury.
1/2018	The reduction of heparan sulphate in the glomerular basement membrane does not augment urinary albumin excretion.
5/2014	Podocyte injury enhances filtration of liver-derived angiotensinogen and renal angiotensin II generation.
1/2014	Kidney Diseases Enhance Expression of Tetraspanin-8: A Possible Protective Effect against Tubular Injury.
7/2012	Liver angiotensinogen is the primary source of renal angiotensin II.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Taiji Matsusaka Research Topics

Disease

12	Proteinuria 01/2018 - 04/2005
10	Fibrosis (Cirrhosis) 11/2022 - 12/2002
6	Sclerosis 01/2017 - 04/2005
5	Kidney Diseases (Kidney Disease) 11/2022 - 07/2012
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 01/2016
4	Inflammation (Inflammations) 01/2021 - 01/2017
4	Starvation 01/2019 - 01/2016
4	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2019 - 06/2005
3	Glomerulonephritis 01/2024 - 01/2017
3	Albuminuria 01/2023 - 01/2017
3	Ureteral Obstruction 11/2022 - 03/2011
3	Hypoxia (Hypoxemia) 01/2022 - 12/2017
3	Reperfusion Injury 01/2022 - 01/2019
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2024 - 11/2008
2	Thrombosis (Thrombus) 01/2023 - 03/2015
2	Body Weight (Weight, Body) 10/2020 - 05/2014
2	Edema (Dropsy) 01/2019 - 04/2005
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 01/2017
2	Hypertension (High Blood Pressure) 01/2017 - 01/2016
2	Hyperplasia 01/2014 - 05/2009
1	IGA Glomerulonephritis (IGA Nephropathy) 01/2024
1	Lupus Nephritis 01/2024
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2024
1	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2024
1	Wounds and Injuries (Trauma) 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Ischemia 10/2020

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2005
5	Immunotoxins (Immunotoxin)IBA 01/2019 - 04/2005
5	Angiotensin IIIBA 01/2016 - 07/2012
4	nephrinIBA 01/2023 - 04/2010
4	Low Density Lipoprotein Receptor-Related Protein-2IBA 01/2021 - 11/2008
4	Adenosine Triphosphate (ATP)IBA 01/2021 - 10/2017
4	AngiotensinogenIBA 01/2016 - 07/2012
3	Messenger RNA (mRNA)IBA 01/2022 - 03/2015
3	Nonesterified Fatty Acids (NEFA)IBA 01/2021 - 11/2013
3	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2021 - 01/2016
3	Sirolimus (Rapamycin)FDA Link 01/2021 - 01/2019
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 10/2017
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2024 - 01/2014
2	Plasminogen Activator Inhibitor 1IBA 01/2023 - 03/2015
2	AldosteroneIBA 01/2023 - 01/2017
2	SaltsIBA 01/2023 - 01/2017
2	p38 Mitogen-Activated Protein KinasesIBA 01/2023 - 01/2017
2	FibrinIBA 01/2023 - 01/2010
2	AngiotensinsIBA 01/2022 - 01/2002
2	4,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA 01/2021 - 10/2020
2	Phosphotransferases (Kinase)IBA 01/2021 - 10/2020
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021 - 10/2020
2	Periodic AcidIBA 01/2021 - 10/2020
2	Bovine Serum AlbuminIBA 01/2021 - 10/2020
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 10/2020
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 10/2020
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2021 - 10/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2020
2	Oleic Acid (Oleate)IBA 01/2021 - 10/2020
2	CollagenIBA 01/2021 - 04/2005
2	Ribosomal Protein S6IBA 01/2021 - 10/2020
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2021 - 10/2020
2	Green Fluorescent ProteinsIBA 01/2021 - 01/2016
2	Lysosomal-Associated Membrane Protein 1IBA 01/2021 - 10/2020
2	Streptozocin (Streptozotocin)FDA Link 01/2019 - 01/2017
2	TOR Serine-Threonine KinasesIBA 01/2019 - 11/2013
2	AlbuminsIBA 01/2017 - 11/2013
2	5-bromo-4-chloro-3-indolyl beta-galactoside (X-gal)IBA 01/2014 - 05/2009
2	Type 1 Angiotensin ReceptorIBA 04/2010 - 12/2002
1	S100 Calcium-Binding Protein A4IBA 12/2023
1	CreatinineIBA 01/2023
1	NPHS2 proteinIBA 01/2023
1	Neutralizing AntibodiesIBA 01/2023
1	isolevuglandinIBA 11/2022
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2022
1	pimonidazoleIBA 01/2021
1	PPAR gammaIBA 01/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021
1	Diacylglycerol O-AcyltransferaseIBA 01/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2021
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2021
1	oxalylglycineIBA 01/2021
1	N(6)-carboxymethyllysine (carboxymethyllysine)IBA 01/2021
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2021
1	peroxisome-proliferator-activated receptor-gamma coactivator-1IBA 01/2021
1	alpha 1 Chain Collagen Type IIBA 01/2021
1	Eicosapentaenoic AcidIBA 01/2021
1	bafilomycin A1IBA 10/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 10/2020
1	Glucose (Dextrose)FDA LinkGeneric 10/2020
1	Hematoxylin (Haematoxylon)IBA 10/2020
1	ElementsIBA 10/2020
1	Insulin (Novolin)FDA Link 10/2020
1	NitrogenIBA 10/2020
1	Peptide Initiation Factors (Initiation Factor)IBA 10/2020
1	Chloroquine (Aralen)FDA LinkGeneric 10/2020
1	Cathepsin DIBA 10/2020
1	Carrier Proteins (Binding Protein)IBA 10/2020
1	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 10/2020
1	SterolsIBA 10/2020
1	AndrogensIBA 10/2020

Therapy/Procedure

1	Euthanasia (Mercy Killing) 11/2022